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Background. Voltage mapping allows identifying the arrhythmogenic substrate during scar-related ventricular arrhythmia (VA)
ablation procedures. Slow conducting channels (SCCs), defined by the presence of electrogram (EGM) signals with delayed
components (EGM-DC), are responsible for sustaining VAs and constitute potential ablation targets. However, voltage mapping,
as it is currently performed, is time-consuming, requiring a manual analysis of all EGMs to detect SCCs, and its accuracy is limited
by electric far-field. We sought to evaluate an algorithm that automatically identifies EGM-DC, classifies mapping points, and
creates new voltage maps, named “Slow Conducting Channel Maps” (SCC-Maps). Methods. Retrospective analysis of elec-
troanatomic maps (EAM) from 20 patients (10 ischemic, 10 with arrhythmogenic right ventricular dysplasia/cardiomyopathy)
was performed. EAM voltage maps were acquired during sinus rhythm and used for ablation. Preprocedural contrast-enhanced
cardiac magnetic resonance (Ce-CMR) imaging was available for the ischemic population. +ree mapping modalities were
analysed: (i) EAM voltage maps using standard (EAM standard) or manual (EAM screening) thresholds for defining core and
border zones; (ii) SCC-Maps derived from the use of the novel SCC-Mapping algorithm that automatically identify EGM-DCs
measuring the voltage of the local component; and (iii) Ce-CMR maps (when available). +e ability of each mapping modality in
identifying SCCs and their agreement was evaluated. Results. SCC-Maps and EAM screening identified a greater number of SCC
entrances than EAM standard (3.45± 1.61 and 2.95± 2.31, resp., vs. 1.05± 1.10; p< 0.01). SCC-Maps and EAM screening highly
correlate with Ce-CMR maps in the ischemic population when compared to EAM standard (Lin’s correlation = 0.628 and 0.679,
resp., vs. 0.212, p< 0.01). Conclusion. +e SCC-Mapping algorithm allows an operator-independent analysis of EGM signals
showing better identification of the arrhythmogenic substrate characteristics when compared to standard voltage EAM.
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1. Introduction
Voltage mapping allows the characterization of myocar-
dial scar, being a useful tool for ablation of scar-related
ventricular arrhythmias (VA) [1–3]. Small bundles of
viable cardiac myocytes within the scar create slow
conducting channels (SCCs) that are responsible of the
formation of reentrant circuits promoting VA [3–9].
Computer software for electroanatomical mapping
(EAM) allows the quantification of local electrogram
(EGM) voltages as the peak-to-peak differences of each
bipolar EGM signal [10]. However, far-field activity from
surrounding healthy tissue can result in underestimation
of the scar area and may lead to a worse definition of EGM
signals with delayed components (EGM-DC), thus
masking the presence of SCCs.
+e “scar dechanneling” technique has been introduced
as a substrate ablation strategy for scar-related VAs, either
for ischemic or nonischemic cardiomyopathy [8, 9, 11].
Briefly, this technique is based on bipolar voltage mapping of
the scar during sinus rhythm (SR), analysis of EGMs to
identify SCCs, and ablation of all the identified SCC en-
trances. Outcomes of the “scar dechanneling” technique
depend on the correct identification and elimination of all
present SCCs [9]. +is can be a time-consuming and skill-
demanding task, being subject to significant interoperator
variability. We hypothesize that an automatic system able to
identify EGM-DC within the substrate could simplify and
standardize VA ablation procedures.
In this study, we present and evaluate the performance
of a novel algorithm for automatic EGM analysis so called
“Slow Conducting Channel Mapping” algorithm, or
“SCC-Mapping.” +is algorithm dichotomizes normal
from abnormal bipolar EGMs, automatically identifying
the presence of EGM-DC within the substrate. By mea-
suring the bipolar voltage belonging to the local-field
component, the SCC-Mapping algorithm may obtain
more accurate bipolar voltage maps. +us, a better scar
characterization could help to guide scar-related VA
ablation procedures.
2. Methods
2.1. Patient Sample. Twenty patients (fifteen males) with VA
who underwent catheter-based radiofrequency ablation
were included in the study. Ten patients (nine males) had
ischemic cardiomyopathy. Ten (six males) fulfilled Task
Force criteria for arrhythmogenic right ventricular dyspla-
sia/cardiomyopathy (ARVD/C). Ischemic patients were
selected from our database of VA substrate ablation as
consecutive patients having preprocedural contrast-en-
hanced cardiac magnetic resonance (Ce-CMR) imaging
study. Basal characteristics of the population are summa-
rized in Table 1. +e study complied with the Declaration of
Helsinki, and the local ethics committee approved the study
protocol. All participants included in the study provided
informed written consent.
2.2. Mapping and Ablation Procedure. Electroanatomical
maps (EAM) were obtained with the CARTO3® navigationsystem (Biosense Webster, Inc., Diamond Bar, CA, USA)
using a 3.5mm irrigated-tip +ermoCool® SmartTouch®catheter (Biosense Webster, Inc., Diamond Bar, CA, USA)
for mapping and ablation. Bipolar electrograms were filtered
from 30 to 250Hz. +e 12-lead surface electrocardiogram
(ECG) and EGM signals from the mapping catheter were
displayed and stored for prospective analysis. Endocardial
EAM maps were acquired for all patients belonging to the
ischemic subpopulation and in seven of the patients from the
ARVD/C subpopulation, the rest of EAM maps of the
ARVD/C subpopulation were obtained from the
epicardium.
Ablation was performed under conscious sedation or
general anaesthesia when epicardial access was required or
anticipated. Bipolar voltage maps were obtained during SR
and scar was identified using standard voltage thresholds
defining scar core zone (CZ) (<0.5mV), border zone (BZ)
(<1.5mV), and healthy tissue (≥1.5mV). +e “scar
dechanneling” ablation technique was used for identification
and ablation of SCC entrances, thus isolating the VA
isthmuses [9]. Identification of SCC was performed man-
ually by the EAM navigation system operator. After ablation
of all the SCC entrances, a remap procedure was performed
to detect any residual SCC and ablate them if needed. When
finished, a programmed stimulation protocol was per-
formed, remapping again the substrate in case any sustained
VAs were found inducible, until noninducibility was
achieved. Ablation was performed in temperature-con-
trolled mode with 45°C temperature and 50W power limit at
26mL/min irrigation rate (40W and 17mL/min at
epicardium).
2.3. Ce-CMR Acquisition and Processing. A preprocedural
late gadolinium Ce-CMR was acquired in all ischemic cases
and used to localize the arrhythmogenic substrate [12]. +e
preprocedural Ce-CMR studies were obtained using a 3T
scanner (MAGNETOM® Trio®, Siemens Healthcare,Erlangen, Germany). Contrast-enhanced images were









Age (years) 57± 15 69± 8 45± 9 <0.001
Sex (male) 15 (75%) 9 (90%) 6 (60%) 0.303
Hypertension
(n) 7 (35%) 6 (60%) 1 (10%) 0.057
Dyslipidemia
(n) 8 (40%) 7 (70%) 1 (10%) 0.020
LVEF (%) 44± 16 35± 20 49± 14 0.193
EAM points (n) 532± 212 438± 208 626± 180 0.076
Values are given as mean± standard deviation or n (%). ∗p-value refers to
the comparison between ischemic and ARVD/C populations. ARVD/C:
arrhythmogenic right ventricular dysplasia/cardiomyopathy; LVEF: left
ventricular ejection fraction; and EAM: electroanatomical mapping.
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acquired 10 minutes after bolus injection of 0.2mmol/kg
Gadobutrol (Gadovist®, Bayer Hispania, Barcelona, Spain)using a commercially available, free-breathing, ECG-gated,
navigator-gated, 3D inversion-recovery, gradient-echo
technique.
Ce-CMR images were analysed as previously described
[12]. Briefly, a full left ventricular (LV) volume was
reconstructed in the axial orientation, and the resulting
images were processed with the commercially available
ADAS-3D™ software (Galgo Medical, Barcelona, Spain).
Ten concentric surface layers (from 10% to 90%) were
created automatically from endo- to epicardium of the LV
wall thickness. A 3D shell was obtained for each layer.
Pixel signal intensity (PSI) maps based on Ce-CMR im-
ages were projected to each shell, following a trilinear
interpolation algorithm, and colour-coded. To identify the
scar areas, a PSI-based algorithm was applied to char-
acterize the hyperenhanced area as CZ, BZ or healthy
tissue using 40% ± 5% and 60% ± 5% of the maximum
intensity as thresholds [12]. +e BZ channels (i.e., SCCs)
were defined by the ADAS-3D™ software as continuous
3D corridors (across all the Ce-CMR layers) of BZ (with
the specified PSI threshold) surrounded by scar core/
mitral annulus [12].
2.4. @e “Slow Conducting Channel Mapping” (“SCC-Map-
ping”) Algorithm. +e SCC-Mapping algorithm is based on
an EGM detector and delineator algorithm previously de-
veloped by our team [13]. +is detector automatically
identifies and delineates the onset and end landmarks of the
bipolar EGM signal using the QRS complex of the 12-lead
surface ECG as the reference searching window, a method
that has been already validated for activation mapping of
focal VA [13, 14]. +e entire processing algorithm was
implemented in MATLAB® (MATLAB R2016a, Math-Works, Inc., Natick, MA, USA). +e results were obtained
offline; therefore, ablation outcomes were independent of
the presented results.
Starting from an initial delineation of the mapping point
EGM signal using our EGM detector/delineator algorithm
[13], the SCC-Mapping algorithm uses a decision tree il-
lustrated in Figure 1(a). +is decision tree is based on two
main characteristics of the bipolar EGM signal: the delin-
eated length and the bipolar voltage.
For short-duration EGMs (<65ms, based on [15]),
normal mapping points are distinguished from those can-
didates to be an EGM-DC by the measured bipolar voltage.
+erefore, those mapping points showing a bipolar voltage
≥3.5mV were considered normal EGMs [15], whereas the
rest were candidates for being classified as EGM-DC or
remained as normal EGMs. Long-duration EGMs (>65ms)
were always considered potential candidates for EGM-DC,
regardless of their voltage value.
In order to label an EGM-DC candidate with true
delayed (d-EGM) or fused (f-EGM) components, the al-
gorithm searched for the existence of a second EGM
component based on the EGM detector/delineator algo-
rithm [13]. If a second EGM component was found, the time
distance between the main deflection of far- and local-field
component (i.e., the first and the second component) di-
chotomized between d-EGMs and f-EGMs (see Figure 1(a)).
+e cut-off threshold was set to 25ms as a trade-off for good
identification of f-EGM and d-EGM signals. f-EGMs were
ablation targets according to the “scar dechanneling”
technique, as they constitute the typical pattern at SCC
entrances [9].
+e outcome of the algorithm is the identification label
on the type of EGM assigned to each mapping point. +ese
labels were then colour-coded and integrated into the 3D
EAM with the following criteria: small white spheres for
normal EGM mapping points; blue big spheres for d-EGM
mapping points, and black big spheres for f-EGMs mapping
points.
2.5. Construction of SCC-Maps. +e SCC-Mapping algo-
rithm identifies the existence of potential EGM-DC,
allowing to measure the bipolar amplitude of far- and
local-field components individually. +e projection of
these voltages on a 3D SCC-Map was performed using an
additional decision tree (Figure 1(b)) with two branches:
one for single-component EGMs and another for EGM-
DC (either d-EGMs or f-EGMs). +e single-component
EGM branch considered any mapping point <1.5 mV as
far-field remote signals measured within the dense scar
coming from the surrounding healthy myocardium,
automatically setting its bipolar voltage to zero. +e
double-component EGM branch projects on the 3D SCC-
Map the bipolar voltage of the local-field component only
if it is included within a window of interest. +is window
of interest was defined between the 5th and 95th per-
centiles of the onsets and ends of all identified local-field
components, respectively. If the local-field component of
an EGM-DC mapping point did not meet this criterion,
then the same criterion as for single-component EGM
mapping points was applied. Additionally, the algorithm
includes a spatial coherence protection. +is protection
checks, for close EGM-DC mapping points (dis-
tance < 6mm), if the local-field components are similar in
activation time and shape. When these criteria are met,
only the highest bipolar value is represented in the 3D
SCC-Map.
2.6. SCC Detection Agreement Evaluation. In this study,
three mapping modalities were considered: (i) EAM voltage
maps, (ii) SCC-Maps derived from the SCC-Mapping Al-
gorithm; and (iii) Ce-CMR PSI maps (when available). An
expert operator visually evaluated the ability of each map-
ping modality to identify SCC entrances from both the 3D
coloured map and the acquired EGM signals.
2.6.1. Identification of SCC Entrances Derived from the 3D
Coloured Map. For the EAM voltage maps, SCC entrance
identification was performed using (1) the standard
thresholds that define the presence of scar CZ and BZ
tissue (named “EAM standard”); and (2) using a manual
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voltage screening process that dynamically modifies the
standard thresholds for BZ and CZ definition in order to
enhance the presence of SCCs (named “EAM screening”)
[3, 16]. For the SCC-Maps, this process was done directly
from the coloured map. It should be noted that, due to the
more precise bipolar voltage measurement method of
SCC-Maps, the CZ tissue threshold was set to ≤0.1mV,
yielding a higher range of bipolar voltage measurements
(shown and discussed in the following sections). +ere-
fore, the voltage screening process was not necessary for
SCC-Maps. For the Ce-CMR PSI maps, the threshold
definitions for tissue heterogeneity identification (i.e., BZ
tissue that conforms SCCs) were those explained in the
corresponding section.
2.6.2. Identification of SCC Entrances Derived from the
Analysed EGM Signals. +is process was done by manual
inspection of the presence or absence of f-EGMs in the
identified (labelled) mapping points close to the BZ area.
+erefore, this evaluation could only be done for EAM
voltage maps and SCC-Maps.
2.7. Statistical Analysis. Continuous data are shown in
mean± standard deviation, unless otherwise indicated.
Categorical data are shown as percentages. Comparison
between different populations was given by the Wilcox-
on–Mann–Whitney test or by the Fisher exact test when
appropriate. For evaluation of the agreement in the SCC
entrances identification among the different mapping mo-
dalities, Wilcoxon–Mann–Whitney test, Lin’s concordance
correlation factor “ρ” [17], and Bland–Altman plot analysis
[18] were used. A p-value of ≤0.05 was considered as a cut-
off value for statistical significance. Statistics were obtained
using the MATLAB statistics toolbox (MATLAB R2016a,
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Figure 1: +e “Slow Conducting Channel Mapping Algorithm.” (a) Decision tree for electrogram (EGM) signals with delayed components
(EGM-DC) searching protocol and (b) algorithm for the reconstruction of “Slow Conducting Channel Maps” (SCC-Maps) on patient’s 3D
anatomical map. VSCC-Map: bipolar voltage projected on patient’s 3D anatomical map.
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3. Results
3.1. Population Characteristics. Twenty patients were in-
cluded in the study. 75% were male, and mean age was
57± 15 years. Mean LV ejection fraction was 44± 16%, with
no significant differences between ischemic patients and
those with ARVD/C. Table 1 summarizes the baseline
characteristics of the study population.
3.2. SCC Detection Agreement between EAM and SCC-
Mapping. Table 2 and Figure 2(a) show the agreement in
the number of SCC entrances identified from the 3D
coloured maps between all the studied mapping modal-
ities. EAM voltage maps with standard thresholds (“EAM
standard”) presented a significant lower number of SCC
entrances than EAM voltage maps with manual voltage
screening (“EAM screening”) (p< 0.01, 0.04, and 0.03 for
the entire population, ischemic, and ARVD/C, resp.).
Additionally, EAM standard maps also had less SCC
entrances than SCC-Maps (p< 0.01, < 0.01, and 0.02 for
the entire population, ischemic, and ARVD/C, resp.).
However, there were no significant differences in the
number of identified SCC entrances between EAM
screening maps and SCC-Maps (p � 0.29, 0.10, and 0.87
for the entire population, ischemic, and ARVD/C, resp.).
Lin’s concordance correlation factor analysis shown in
Supplementary Table 1 supports these findings, showing a
higher concordance between EAM screening and SCC-
Maps (ρ� 0.665, 0.528, and 0.877 for the entire pop-
ulation, ischemic, and ARVD/C, resp.) than EAM stan-
dard maps.
+e Bland–Altman analysis shown in Figure 2(a) illus-
trates the agreement in SCC entrance identification among
the different studied mapping modalities and populations.
+ere was a low bias in the number of SCC entrances
identified between SCC-Maps and EAM screening maps,
with a small trend towards a SCC subidentification of SCC-
Maps compared with EAM screening maps (Pearson’s
R� 0.48, p � 0.033), which is in concordance with the
findings of Table 2.
Table 3 and Figure 2(b) list the agreement in the number
of SCC entrances identified from the f-EGM points between
mapping modalities. No significant differences were found
between EAM standard maps and SCC-Maps, confirmed by
the Bland–Altman analysis shown in Figure 2(b) and the
high correlation shown in Supplementary Table 2 (ρ� 0.918,
0.871, and 0.936 for the entire population, ischemic, and
ARVD/C, resp.).
Figure 3 illustrates two examples of the electrical
propagation sequences along SCCs identified from the au-
tomatically labelled mapping points on SCC-Maps com-
pared to the SCC manual identification performed on EAM
maps where the identification of these SCCs requires ex-
tensive operator analysis.
3.3. SCCDetection Agreement with Ce-CMR. +e number of
SCC entrances identified in EAM standard was signifi-
cantly lower compared with Ce-CMR PSI maps, as shown
in Table 2. However, no significant differences were found
between EAM screening and SCC-Maps versus Ce-CMR
PSI maps (p � 0.202 and p � 1.0, resp.). Nevertheless,
Bland–Altman plot analysis reveals a tendency of these
three mapping modalities towards an underestimation of
the number of SCC entrances compared with Ce-CMR PSI
maps (Pearson’s R � 0.63, p � 0.049; R � 0.85, p � 0.002;
and R � 0.61, p � 0.05 for the comparisons between SCC
detection on SCC-Maps, EAM standard, and EAM
screening against Ce-CMR PSI maps, resp., Figure 2(c)).
Moreover, Supplementary Table 1 confirms the high
agreement of EAM screening and SCC-maps with Ce-CMR
PSI maps compared with EAM standard (ρ� 0.679 and
ρ� 0.628, resp., vs. ρ� 0.212, p< 0.01). Figure 4 shows two
examples where SCC-Maps had higher agreement with Ce-
CMR PSI maps in identifying SCC, as compared to EAM
standard maps.
3.4. Effect of Selective Bipolar Voltage Measurement. +e
SCC-Mapping algorithm was capable of detecting EGM-
DC providing the bipolar voltage of the local component,
thus obtaining accurate voltage maps (SCC-Maps). +is
more selective approach enlarged the voltage range dis-
played and thus improved the degree of detail of the
arrhythmogenic substrate when compared with standard
EAM voltage maps. Figure 5(b) illustrates the loss of scar
details in EAM voltage maps when compared to SCC-
Maps, which display a higher range of voltage measure-
ments. Additionally, as depicted in Figure 4, SCC-Maps
matched better with information obtained from Ce-CMR
PSI maps in the ischemic population than EAM standard
maps.
4. Discussion
4.1. Reviewing Current Bipolar Voltage Mapping. EAM
systems are useful tools to map scar-related VAs, since
they allow calculating the peak-to-peak local EGM signal
amplitude and representing this value, colour-coded, on
the cardiac anatomy, thus helping to identify and char-
acterize the scar [3, 5, 6, 8–10, 19, 20]. However, myo-
cardial scars are often surrounded by a considerable
amount of healthy tissue, which may lead to local EGMs
being masked by the presence of far-field signals.
+erefore, regular voltage mapping with standard
thresholds may underestimate of the scar size and lose
significant scar details. +is increases the likelihood of
missing SCCs within the substrate and the need of ex-
tensive operator analysis.
Examples of this phenomenon are illustrated in Figure 6.
In normal EGMs, the voltage map reflects the peak-to-peak
voltage (a); however, when healthy myocardium EGM (i.e.,
far-field) has a higher amplitude than the late potential (i.e.,
local-field), the voltage map reflects the far-field, high-
amplitude component voltage (b). Moreover, when the far-
and local-field components show comparable amplitudes,
voltage mapmay reflect the peak-to-peak amplitude of either
the local or the far-field component (c), or a mix of both (d).
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Table 2: Analysis of colour-coded maps. Number of SCC entrances identified per patient and agreement between mapping modalities.
EAM standard EAM screening SCC-Map Ce-CMR PSI maps p-value∗ p-value† p-value‡
Entire population (n� 20) 1.05± 1.10 2.95± 2.31 3.45± 1.61 N/A <0.01 <0.01 0.29
Ischemic (n� 10) 0.60± 1.00 2.20± 1.75 3.60± 1.43 3.70± 2.45 0.04 <0.01 0.10
ARVD/C (n� 10) 1.50± 1.08 3.70± 2.63 3.30± 1.83 N/A 0.03 0.02 0.87
Number of SCC entrances per patient are given as mean± standard deviation. ∗Differences between EAM standard and EAM screening. †Differences between
EAM standard and SCC-Maps. ‡Differences between EAM screening and SCC-Maps. ARVD/C: arrhythmogenic right ventricular dysplasia/cardiomyopathy;
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Figure 2: Continued.
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Figure 2: Bland–Altman plots for assessing the agreement in the identification of slow conducting channel (SCC) entrances (a) from the
colour-coded 3D maps between the different mapping modalities: electroanatomical mapping (EAM) system maps with standard voltage
thresholds (EAM standard), EAM maps with voltage screening (EAM screening), and “Slow Conducting Channel Maps” (SCC-Maps). (b)
From the analysis of the presence of fused electrograms (f-EGM) components between EAM standardmaps and SCC-Maps and (c) from the
colour-coded 3D map between the different mapping modalities and the pixel signal intensity (PSI) maps derived from contrast-enhanced
cardiac magnetic resonance (Ce-CMR) imaging in the ischemic population. Red solid line indicates mean and red dashed lines indicate
mean± 2 standard deviations of the difference in the number of identified SCC entrances. ARVDC: arrhythmogenic right ventricular
dysplasia/cardiomyopathy.
Table 3: Analysis of EGM-DC and identification of f-EGMs. Number of SCC entrances identified per patient and agreement between
mapping modalities.
EAM maps SCC-Map p-value
Entire population (n� 20) 6.10± 2. 81 5.35± 2.70 0.430
Ischemic (n� 10) 5.50± 2.17 4.70± 2.11 0.422
ARVD/C (n� 10) 6.70± 3.34 6.00± 3.16 0.790
Number of SCC entrances per patient are given as mean± standard deviation. ARVD/C: arrhythmogenic right ventricular dysplasia/cardiomyopathy; EAM:
electroanatomical mapping; EGM-DC: electrograms with delayed components; f-EGM: fused electrograms; and SCC: slow conducting channel.
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Figure 3: Examples of slow conducting channel (SCC) identification from the automatic mapping point labelling on “Slow Conducting
Channel Maps” (SCC-Maps). (a) Endocardial electroanatomical map (EAM) of an ischemic patient showing two SCCs identified on SCC-
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Figure 4: Agreement between electroanatomical mapping (EAM) voltage maps and “Slow Conducting Channel Maps” (SCC-Maps) against
pixel signal intensity (PSI) maps derived from contrast-enhanced cardiac magnetic resonance (Ce-CMR) imaging. A1 and B1 show the
electroanatomical mapping (EAM) voltage maps obtained with the EAM system from two different patients. A2 and B2 show the cor-
responding SCC-Map and A3 and B3 show the acquired Ce-CMR PSI map. AV: aortic valve.
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Figure 5: Endocardial substrate map from patient with myocardial infarction. (c) illustrates the richest scar details shown by the “Slow
Conducting Channel Map” (SCC-Map) compared with electroanatomical mapping (EAM) voltage maps using the standard voltage
thresholds (a) and using modified voltage thresholds (b).
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+ese examples show the need of a more selective approach
to measure bipolar voltage for substrate mapping of scar-
related VAs.
4.2. Main Findings. +e present study evaluates a novel
automatic EGM signal analysis algorithm aiming to im-
prove the accuracy of current voltage mapping obtained
with EAM systems. +is algorithm allows obtaining voltage
maps with higher voltage range, hence depicting more
detailed scar characteristics, which may be useful to
identify VA isthmuses during ablation procedures. +e
main findings of the study are as follows: (1) the proposed
SCC-Mapping algorithm automatically identified SCC
entrances at the same level as manual EAM voltage
screening; (2) the SCC-Mapping algorithm provided SCC-
Maps that match Ce-CMR PSI maps better than current
EAM voltage maps; and (3) the SCC-Mapping algorithm
improves the definition of the scar CZ and BZ areas by
allowing a higher voltage range.
4.3. SCC Detection and Agreement between Mapping
Modalities. SCC-Maps were highly correlated with EAM
standard maps when these were obtained after a manual
voltage screening process (EAM screening), whereas raw
EAM standard maps (EAM standard) correlated worse
and identified a significant lower number of SCC en-
trances. +e algorithm’s accuracy is illustrated by the fact
that SCC-Maps can display a detailed scar without the
need of manual voltage screening, with good agreement
with EAM after manual labelling of the mapping points
corresponding to SCC entrances (i.e., those showing
f-EGM signals).
Figure 3 shows ischemic and ARVD/C patient ex-
amples where two different SCCs can be found. Both
examples illustrate the superiority of SCC-Maps over
EAM standard maps, allowing the identification of those
signal corridors by direct inspection of the colour map.
+e EAM standard map of Figure 3(a) (panel A1) depicts a
dense scar in the area where a second SCC can be found
following the activation sequence of the d-EGMs. +is
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Figure 6: Examples of (a) normal electrogram (EGM) bipolar voltage measurement by the electroanatomical mapping (EAM) system and
(b–d) different bipolar EGM-DC signals with incorrect bipolar voltage measurement by the EAM system: (b) local-field component masked
by high-amplitude far-field component. (c-d) Comparable amplitude of far-field and local-field components.
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automatic labelling in Figure 3(a) (panel A2). Similarly,
the EAM standard map of Figure 3(b) (panel B1) does not
allow to identify those SCCs that can be seen in the SCC-
Map of Figure 3(b) (panel B2). Moreover, SCC-Maps and
EAM-screening correlate better than EAM-standard maps
with Ce-CMR PSI maps. +ese examples illustrate the
need of manual analysis of the EGM signals by the system
operator in order to identify all the possible SCCs present
in the substrate (i.e., using techniques like manual voltage
screening and individual EGM labelling). +is procedure
can be guided and shortened by the proposed automatic
SCC-Mapping algorithm. Moreover, automatic and ob-
jective identification becomes mandatory when using the
increasingly popular multielectrode mapping (MEM)
catheters where tenths of simultaneous signals per beat
can be acquired.
4.4. Voltage @resholds for Scar Definition. +e proposed
SCC-mapping algorithm provides a more precise quanti-
fication of the local-field voltage. +is aspect allows
changing the threshold definition for CZ tissue without
losing scar information, thus improving the ability to
detect of SCC (Figure 4). +is effect is comparable to the
one obtained with current MEM catheters [21], but using
a regular electrode-size catheter in conjunction with an
automatic algorithm to distinguish the far- and local-field
components of the measured EGMs. In contrast, MEM
catheters still need extensive operator analysis in order to
identify and/or enhance the presence of SCCs. +is fact
could be mitigated if high-density mapping is combined
with an automatic algorithm as the presented in this
work.
Figure 5 illustrates the loss of scar definition when the
modified voltage threshold for BZ and CZ tissue is used on
EAM voltage maps. +e higher voltage range displayed by
SCC-Maps also facilitates the voltage screening process
for SCC identification. However, although SCC-Maps and
EAM screening maps provide similar insights, the former
were obtained without any manual intervention, thus
being operator independent. Additionally, as shown in
Figures 3–5, it can be observed that SCC-Maps provided a
better defined scar delineation than current EAM voltage
mapping.
+e proposed algorithm was evaluated when using the
“scar dechanneling” ablation technique. However, the fact
that a higher voltage range can be described with SCC-
Maps allows a more detailed scar characterization, which
suggests that the algorithm can also be useful for other
ablation approaches [5, 22–25]. Eventually, the SCC-
Mapping algorithm could effectively improve the guid-
ance of pacing/entrainment manoeuvres for VA isthmus
identification based on the tagged data and SCC-Map
information.
4.5. Study Limitations. +e main limitation of this study
was the relatively small sample size. Comparison of EAM
maps against Ce-CMR PSI maps was only possible in the
ischemic population due to the presence of implantable
devices in the ARVD/C population. On the other hand,
the number of available patients with detailed EAM and
quality Ce-CMR data has reduced lately, as detailed EAM
acquisition is a time-consuming and highly operator-
dependent task, while Ce-CMR-guided catheter substrate
ablation has gained more interest [26]. Despite this trend,
the endpoints for determining the ablation targets are still
based on EAM findings where the presented algorithm can
play an important and complementary role. Also, this
algorithm paves the way for better integration of Ce-CMR
and EAM data to improve scar-related VT ablation
procedures.
Additionally, the algorithm was designed and tested
using data from substrate-based VA ablation during SR.
Hence, no data from VAmapping was used or analysed with
this algorithm and therefore, other possible VA isthmuses
were not explored with this algorithm [27].
In this work, EAMs were acquired using a standard
3.5 mm irrigated-tip mapping catheter, which has a
longer interelectrode distance as compared with high-
density MEM catheters that can better discriminate lo-
cal- from far-field components [21]. However, manual
annotation of multiple simultaneous signals obtained
with MEM is a nonaffordable task, for which an auto-
matic approach (like the SCC-Mapping algorithm) be-
comes necessary.
5. Conclusions
+e proposed automatic analysis of EGM signals using the
“Slow Conducting Channel Mapping Algorithm” improves
the accuracy of bipolar voltagemeasurements within the scar
area, achieving a more detailed tissue characterization and
being an operator-independent tool for accurate identifi-
cation of SCCs. +is last feature encourages the use of the
algorithm together with EAM navigation systems as a re-
producible approach for guiding VA ablation procedures in
daily practice.
Data Availability
+e electroanatomical mapping and image data used to
support the findings of this study are restricted by the
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